期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
阿立哌唑临床应用专家建议 被引量:5
1
作者 刘登堂 司天梅 +8 位作者 郑毅 李凌江 张宁 张聪沛 李涛 马现仓 李毅 杨甫德 江开达 《临床精神医学杂志》 CAS 2021年第5期337-341,共5页
阿立哌唑属于非典型抗精神病药,是多巴胺D2和5-羟色胺(5-HT)1A受体的部分激动剂,作用机制独特。本文介绍了阿立哌唑的药代动力学及药效学特点、临床应用的疗效、安全性及循证证据,从而提出了阿立哌唑的临床应用专家建议。
关键词 阿立哌唑 精神分裂症 专家建议
下载PDF
Association between painful physical symptoms and clinical outcomes in Chinese patients with major depressive disorder:a three-month observational study 被引量:5
2
作者 LI Hui-chun zhang Ming-yuan +11 位作者 WANG Gang zhang Hong-geng zhang Hong-yan LIU Ying LI Ming zhang cong-pei TANG Ji-sheng WU Wen-yuan Pritibha Singh Renee Elizabeth Granger Joel Raskin ANG Qiu-qing 《Chinese Medical Journal》 SCIE CAS CSCD 2010年第15期2063-2069,共7页
Background Painful physical symptoms (PPS) may present as a component of major depressive disorder (MDD).Their effect in Chinese patients has not been investigated.This analysis reports the changes in disease seve... Background Painful physical symptoms (PPS) may present as a component of major depressive disorder (MDD).Their effect in Chinese patients has not been investigated.This analysis reports the changes in disease severity,treatment patterns, quality of life and outcomes in a Chinese cohort according to the presence (PPS+) or absence (PPS-)of painful physical symptoms.Methods A subgroup of Chinese patients from a large observational 3-month study of patients from Asian countries and regions of China were classified using the modified Somatic Symptom Inventory (SSI) as PPS+(mean score≥2) or PPS(mean score 〈2).Depression severity was assessed with the Clinical Global Impression of Severity (CGI-S) scale and 17-item Hamilton depression rating scale (HAMD17).Pain severity was measured using a visual analogue scale (VAS),while the EuroQoL (EQ-5D) assessed patient well-being.Antidepressants were compared with regard to their efficacy.Results Of the 299 Chinese patients enrolled in the study, 105 were classified as PPS+ (73/105, 70% women).At baseline, PPS+ patients reported greater pain severity (VAS, mean (SD): 49.56 (26.49) vs.16.60 (20.99) for PPS-, P 〈0.01), were more depressed (HAMD17, mean (SD): 25.32 (5.47) vs.23.33 (5.24) for PPS-, P=0.002) and had poorer quality of life (EQ-5D Health State, mean (SD): 38.48 (22.38) vs.49.57 (18.54) for PPS-, P 〈0.001).PPS+ patients showed less overall improvement in depressive symptom severity (HAMD17, change from baseline (95% CI):-17.38(-18.65, -16.12) vs.-19.20 (-20.05,-18.35) for PPS-,P=-0.032; CGI-S, change from baseline (95% CI): -2.85(-3.11, -2.58) vs.-3.20 (-3.38, -3.02) for PPS-, P=0.044).Conclusions PPS were less frequent than expected compared with previous studies of Asian populations.PPS+were associated with greater MDD severity and less improvement than PPS- when antidepressants were given. 展开更多
关键词 depressive disorder major PAIN quality of life EPIDEMIOLOGY public health China
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部